Effect of the Procalcitonin Assay on Antibiotic Use in Critically Ill Children

被引：5

作者：

Ross, Rachael K. ^{[1
]}

Keele, Luke ^{[2
]}

Kubis, Sherri ^{[3
]}

Lautz, Andrew J. ^{[4
]}

Dziorny, Adam C. ^{[5
]}

Denson, Adam R. ^{[5
]}

O'Connor, Kathleen A. ^{[5
]}

Chilutti, Marianne R. ^{[6
]}

Weiss, Scott L. ^{[5
]}

Gerber, Jeffrey S. ^{[1
,7
]}

机构：

[1] Univ Penn, Childrens Hosp Philadelphia, Perelman Sch Med, Div Infect Dis,Dept Pediat, Philadelphia, PA 19104 USA

[2] Georgetown Univ, McCourt Sch Publ Policy, Washington, DC USA

[3] Childrens Hosp Philadelphia, Dept Nursing Resp Care & Neurodiagnost Serv, Philadelphia, PA 19104 USA

[4] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Div Crit Care Med, Cincinnati, OH 45229 USA

[5] Univ Penn, Childrens Hosp Philadelphia, Perelman Sch Med, Div Crit Care Med,Dept Anesthesiol & Crit Care, Philadelphia, PA 19104 USA

[6] Childrens Hosp Philadelphia, Dept Biomed & Hlth Informat, Philadelphia, PA 19104 USA

[7] Univ Penn, Childrens Hosp Philadelphia, Perelman Sch Med, Div Gen Pediat,Dept Pediat, Philadelphia, PA 19104 USA

来源：

JOURNAL OF THE PEDIATRIC INFECTIOUS DISEASES SOCIETY | 2018年 / 7卷 / 02期

关键词：

antibiotics; critical care; pediatric; procalcitonin; RANDOMIZED CONTROLLED-TRIAL; BIAS REDUCTION; MULTICENTER; SEPSIS; SENSITIVITY; INFECTIONS; THERAPY; IMPACT;

D O I：

10.1093/jpids/piy004

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

We retrospectively studied the effect of introducing procalcitonin into clinical practice on antibiotic use within a large academic pediatric intensive care unit. In the absence of a standardized algorithm, availability of the procalcitonin assay did not reduce the frequency of antibiotic initiations or the continuation of antibiotics for greater than 72 hours.

引用

页码：E43 / E46

页数：4

共 50 条

[31] The strategy of antibiotic use in critically ill neutropenic patients
Legrand, Matthieu
Max, Adeline
Schlemmer, Benoit
Azoulay, Elie
Gachot, Bertrand
ANNALS OF INTENSIVE CARE, 2011, 1
[32] Usefulness of Semi-quantitative Procalcitonin Assay in Critically Ill Patients with Bacterial Pneumonia
Lee, Seung Hwa
Kim, Cheol-Hong
Kim, Ji Youn
Park, Seon Wook
Kim, Young Wook
Hyun, In Gyu
Woo, Heungjeong
Kim, Hyun Soo
INFECTION AND CHEMOTHERAPY, 2009, 41 (06): : 342 - 348
[33] Procalcitonin Guidance Safely Decreases Antibiotic Use in Critically III Patients
Kulkarni, Nita Shrikant
AMERICAN FAMILY PHYSICIAN, 2016, 94 (08) : 663 - 664
[34] Does Measuring Serum Concentration of Procalcitonin in Critically Ill Patients Assist in Stopping Antibiotic Therapy?
Lam, Simon W.
Bauer, Seth R.
CANADIAN JOURNAL OF HOSPITAL PHARMACY, 2019, 72 (01): : 52 - 53
[35] Procalcitonin Serum Levels: Only a Useful Variable or a Must to Start Antibiotic Therapy in the Critically Ill?
Corona, Alberto
Colombo, Riccardo
Raimondi, Ferdinando
CRITICAL CARE MEDICINE, 2013, 41 (02) : E18 - E19
[36] Pro/Con debate: Is procalcitonin useful for guiding antibiotic decision making in critically ill patients?
Shehabi, Yahya
Seppelt, Ian
CRITICAL CARE, 2008, 12 (03)
[37] Correction to: Procalcitonin-guided antibiotic therapy in critically ill adults: a meta-analysis
Tao Zhang
Yan Wang
Qianting Yang
Yalin Dong
BMC Infectious Diseases, 19
[38] Pro/Con debate: Is procalcitonin useful for guiding antibiotic decision making in critically ill patients?
Yahya Shehabi
Ian Seppelt
Critical Care, 12
[39] Practice Patterns and Outcomes Associated With Procalcitonin Use in Critically Ill Patients With Sepsis
Chu, David C.
Mehta, Anuj B.
Walkey, Allan J.
CLINICAL INFECTIOUS DISEASES, 2017, 64 (11) : 1509 - 1515
[40] Antibiotic coated central venous catheters in critically ill children
Immergluck, LH
Hayani, KC
Starosta, D
Schwartz, A
Keeskes, S
PEDIATRIC RESEARCH, 2003, 54 (05) : 779 - 779

← 1 2 3 4 5 →